---
category: news
title: "Gene therapy startup signs 3rd partnership deal, worth up to $1.8B"
excerpt: "Dyno Therapeutics is now working with two of the four companies that have brought a gene-targeting treatment to market in the U.S. It just signed another deal that could bring it billions in development dollars."
publishedDateTime: 2020-10-14T10:13:00Z
originalUrl: "https://www.bizjournals.com/boston/news/2020/10/14/gene-therapy-dyno-partners-with-roche-spark.html"
webUrl: "https://www.bizjournals.com/boston/news/2020/10/14/gene-therapy-dyno-partners-with-roche-spark.html"
ampWebUrl: "https://www.bizjournals.com/boston/news/2020/10/14/gene-therapy-dyno-partners-with-roche-spark.amp.html"
cdnAmpWebUrl: "https://www-bizjournals-com.cdn.ampproject.org/c/s/www.bizjournals.com/boston/news/2020/10/14/gene-therapy-dyno-partners-with-roche-spark.amp.html"
type: article
quality: 39
heat: 39
published: false

provider:
  name: The Business Journals
  domain: bizjournals.com

topics:
  - AI in Healthcare
  - AI

related:
  - title: "Roche, aiming to make better gene therapies, turns to an emerging startup"
    excerpt: "The Swiss pharma is the third large drugmaker to partner with Harvard spinout Dyno Therapeutics, a small biotech aiming to improve gene therapy technology."
    publishedDateTime: 2020-10-14T15:03:00Z
    webUrl: "https://www.biopharmadive.com/news/roche-dyno-gene-therapy-deal/586993/"
    type: article
    provider:
      name: BioPharma Dive
      domain: biopharmadive.com
    quality: 38
    images:
      - url: "https://www.biopharmadive.com/user_media/cache/5d/7c/5d7cb9b442f6969f3b73b5d122100ebb.jpg"
        width: 770
        height: 364
        isCached: true
  - title: "Dyno, Roche to tackle CNS, liver disease in gene therapy deal worth up to $1.8B"
    excerpt: "Potential partners have approached the Cambridge-based Dyno Therapeutics since its founding two years ago to get in on the action. Today, Dyno announced its third partnership in the last five months: a $1."
    publishedDateTime: 2020-10-14T10:00:00Z
    webUrl: "https://www.fiercebiotech.com/biotech/dyno-and-roche-strike-1-8-billion-deal-to-tackle-gene-therapy-for-central-nervous-system"
    type: article
    provider:
      name: FierceBiotech
      domain: fiercebiotech.com
    quality: 35
    images:
      - url: "https://qtxasset.com/fiercebiotech/1602635473/Dyno%20CEO%20Eric%20Kelsic.jpg?BiOOVycwsBlUmt6119DUNKU0LTeJDqPM"
        width: 2201
        height: 2201
        isCached: true
  - title: "Dyno sparks a $1.8B deal with Roche to develop CNS therapies"
    excerpt: "Privately held Dyno Therapeutics Inc., an early stage biotech company applying artificial intelligence to gene therapy, entered a collaboration and license agreement with Spark Therapeutics Inc. that could bring Dyno milestone payments exceeding $1."
    publishedDateTime: 2020-10-14T23:14:00Z
    webUrl: "https://www.bioworld.com/articles/498961-dyno-sparks-a-18b-deal-with-roche-to-develop-cns-therapies"
    type: article
    provider:
      name: BioWorld
      domain: bioworld.com
    quality: 24
    images:
      - url: "https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Neurology/CNS-illustration.png?height=635&t=1602701261&width=1200"
        width: 847
        height: 635
        isCached: true

secured: "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;2SEyhrVfDm3wrDRXWchTtA=="
---

